Proof that Mycobacterium Abscessus Doesn’t Always Lead to Transplant Failure
Part two of a series. Read part one. Last week, I wrote about how disheartened I felt that many lung transplant centers refuse to help...
Award granted to Neem Biotech to develop antimicrobial intervention for chronic lung infections
Neem Biotech, a Wales based R&D pharmaceutical biotech working in the field of novel antimicrobial drug development, is pleased to...
#ECFS2018 – AB-PA01, with Antibiotics, Shows Promise in Treating Drug-resistant Lung Infections in C
AmpliPhi Biosciences’ investigative therapy AB-PA01, in combination with antibiotics, shows significant potential to treat multi-drug...
Way Found to Use Antimicrobial Peptides, Part of Immune System, to Treat Bacterial Lung and Wound In
Antimicrobial peptides administered as tiny nanoparticles show promise in treating bacterial infections without risking making the...
Celtaxsys Announces Last Patient, Last Visit in Landmark CF Phase 2b Lung Function Preservation Tria
ATLANTA, May 17, 2018 (GLOBE NEWSWIRE) -- Celtaxsys, Inc., a clinical stage pharmaceutical development company focused on advancing...
Gastrointestinal Cancers More Common in Adults with CF, Especially After Transplant, Study Finds
Patients with cystic fibrosis (CF) are at higher-than-average risk of developing gastrointestinal cancers, especially those who underwent...